Susceptibility to radiation-induced normal tissue damage varies among individuals and some of this variation is assumed to have a genetic basis. However, the extent to which naturally occurring genetic polymorphisms influence the severity of normal tissue damage resulting from radiotherapy is unknown. This project is designed to quantify the genetic contribution to observed interindividual variations in radiation-induced normal tissue damage by applying emerging technologies in quantitative genetics in murine model systems. Murine models are suitable for this type of investigation because he strain variations in radiosensitivity result from naturally occurring genetic polymorphisms and there is abundance of radiobiological genetic mapping data available in this species. Preliminary studies revealed strain-specific differences in the levels of radiation-induced thymocyte apoptosis in C57BLJ6J and C3Hf/Kam mice. Genetic analysis of their F2 progeny has allowed the mapping of several of the genes responsible. A similar strain difference was observed in levels of jejunal crypt cell apoptosis, jejunal crypt survival, colon fibrosis and lung fibrosis following irradiation.
The specific aims of this project are to quantitate the genetic components of variation in the levels of radiation-induced apoptosis of thymocyte and jejunal crypt cells and jejunal crypt survival and to determine the inheritance pattern and map the major gene(s) involved in determining the variation in jejunal crypt apoptosis. Studies are planned to categorize radiation- induced apoptosis of thymocytes and jejunal crypt cells, jejunal crypt survival, colon fibrosis and lung fibrosis by their occurrence in C57BL6JXC2Hf/HeJ recombinant inbred mouse strains. In addition, strain differences in injury to clinically important late responding tissues will be characterized and methods to convert radiobiological effect data into quantitative traits that can be manipulated for genetic analyses will be evaluated.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA006294-37
Application #
6101353
Study Section
Project Start
1999-04-15
Project End
2000-02-29
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
37
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Edmondson, Elijah F; Hunter, Nancy R; Weil, Michael M et al. (2015) Tumor Induction in Mice After Localized Single- or Fractionated-Dose Irradiation: Differences in Tumor Histotype and Genetic Susceptibility Based on Dose Scheduling. Int J Radiat Oncol Biol Phys 92:829-36
Neskey, David M; Osman, Abdullah A; Ow, Thomas J et al. (2015) Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer. Cancer Res 75:1527-36
Keck, Michaela K; Zuo, Zhixiang; Khattri, Arun et al. (2015) Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes. Clin Cancer Res 21:870-81
Alsbeih, Ghazi; Brock, Williams; Story, Michael (2014) Misrepair of DNA double-strand breaks in patient with unidentified chromosomal fragility syndrome and family history of radiosensitivity. Int J Radiat Biol 90:53-9
Komaki, Ritsuko; Paulus, Rebecca; Blumenschein Jr, George R et al. (2014) EGFR expression and survival in patients given cetuximab and chemoradiation for stage III non-small cell lung cancer: a secondary analysis of RTOG 0324. Radiother Oncol 112:30-6
Cortez, Maria Angelica; Valdecanas, David; Zhang, Xiaochun et al. (2014) Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer. Mol Ther 22:1494-1503
Bhardwaj, Vikas; Cascone, Tina; Cortez, Maria Angelica et al. (2013) Modulation of c-Met signaling and cellular sensitivity to radiation: potential implications for therapy. Cancer 119:1768-75
Story, Michael; Ding, Liang-hao; Brock, William A et al. (2012) Defining molecular and cellular responses after low and high linear energy transfer radiations to develop biomarkers of carcinogenic risk or therapeutic outcome. Health Phys 103:596-606
Raju, Uma; Riesterer, Oliver; Wang, Zhi-Qiang et al. (2012) Dasatinib, a multi-kinase inhibitor increased radiation sensitivity by interfering with nuclear localization of epidermal growth factor receptor and by blocking DNA repair pathways. Radiother Oncol 105:241-9
Thariat, Juliette; Ang, K Kian; Allen, Pamela K et al. (2012) Prediction of neck dissection requirement after definitive radiotherapy for head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 82:e367-74

Showing the most recent 10 out of 99 publications